How much did community pharmacy funding increase by in 2026/27?

The short answer: the often-quoted £340 million increase was not a new year-on-year increase for 2026/27. It refers to the rise in the Community Pharmacy Contractual Framework (CPCF) funding from 2024/25 to 2025/26. The settlement then set funding at around £3.073 billion for both 2025/26 and 2026/27. On that basis, the headline year-on-year funding increase for 2026/27 was £0: the total was held at the previous year’s level.

That distinction matters for pharmacy owners, managers and workforce planners. A large increase compared with an earlier year can sound like new money in the current year. But if the total stays flat, it does not provide a further uplift to meet rising costs, growing service demand or the staffing pressure associated with delivering Pharmacy First.

This article explains what the £340 million figure means, how to read the CPCF uplift, and why workforce planning needs to look beyond the headline settlement.

The £340 million increase: which years does it compare?

The £340 million figure describes the increase in the overall CPCF funding envelope between 2024/25 and 2025/26. The settlement for 2025/26 was around £3.073 billion. The same headline total was set for 2026/27.

Financial year Headline CPCF funding What the comparison shows 2024/25 Approximately £2.733 billion Baseline year for the commonly quoted £340 million increase 2025/26 Approximately £3.073 billion Approximately £340 million higher than 2024/25 2026/27 Approximately £3.073 billion No additional headline increase compared with 2025/26

These are headline totals, not a promise that every pharmacy receives the same percentage increase in income. The CPCF pays for a range of services and elements, and the way funding reaches individual contractors depends on the relevant payment arrangements, activity and eligibility. Owners should check the official NHS and Department of Health and Social Care guidance for the precise terms applying to their business and the services they provide.

So, how much did funding increase by in 2026/27?

Measured against 2025/26, the year-on-year funding increase for 2026/27 was £0 in the headline CPCF total: funding stayed at approximately £3.073 billion. Measured against 2024/25, the 2026/27 total was still approximately £340 million higher.

Both statements can be true. They answer different questions:

“How much higher is the 2026/27 total than the 2024/25 total?” Approximately £340 million.
“How much new funding was added for 2026/27 compared with 2025/26?” None in the headline total; it was held flat.

This is why it is worth asking which year a funding claim compares with. “A £340 million increase” without a baseline can give the impression that pharmacies received a fresh £340 million uplift in 2026/27. That is not what the year-on-year figures show.

What a flat settlement means in practice

A flat headline total does not automatically mean every pharmacy’s income stays exactly the same. Payments can change with service activity, the mix of services delivered, dispensing volumes and the details of the funding rules. But a flat overall settlement does mean the sector does not receive a further increase to the total envelope compared with the previous year.

Meanwhile, pharmacy costs do not stand still. Employers need to plan for wages, recruitment, training, premises and the practical cost of delivering services. If workload or operating costs rise while the headline funding total stays level, each pharmacy has to examine how it uses its available staff and resources. The headline figure alone cannot tell an owner whether their branch is financially sustainable.

For a useful view, compare the settlement with your own numbers: income by service, staffing hours, locum spend, unfilled shifts, overtime and the time your team spends on work that does not appear in a simple item count. Keep the period consistent—for example, compare the same 12 months year on year—and separate confirmed income from forecasts.

Pharmacy First adds workload to an already busy setting

Pharmacy First has expanded the clinical work community pharmacies can provide for eligible patients. That can improve access and make better use of pharmacists’ skills. It also adds tasks that require time, judgement and coordination: receiving referrals, assessing patients, documenting consultations, managing follow-up and handing over when a patient needs another service.

The workload does not sit in isolation. A pharmacist may be balancing a Pharmacy First consultation with dispensing, clinical checks, other commissioned services, queries from patients and the daily running of the pharmacy. A consultation can also interrupt a planned task or require another team member to cover the counter or workflow. The rota has to account for that time, not just the appointment itself.

Funding for a service and staffing capacity to deliver it are related, but they are not the same thing. A service payment does not instantly create a trained team member or solve a coverage gap. Owners need to consider how many consultations their pharmacy can safely and consistently handle, what support NHS England workforce survey the pharmacist needs, and how to protect time for the rest of the operation.

Why recruitment alone is a fragile workforce plan

When a vacancy appears, advertising for an experienced dispenser or technician may be the obvious first move. In a tight labour market, however, several local employers may be looking for the same people. what is a pharmacy technician A job advert cannot guarantee an applicant, and a successful hire may take time to find, onboard and retain.

Recruitment-only strategies also leave a pharmacy exposed when someone leaves, a candidate withdraws or demand rises faster than the team can grow. The rota then absorbs the shock: existing staff cover extra shifts, managers spend more time filling gaps, and planned training can get pushed aside. Over time, that can make the job harder to sustain for the people who stay.

A stronger approach combines recruitment with development and retention. That means identifying the roles the pharmacy will need, making progression specific, and creating a realistic route for people to gain skills while working. Apprenticeships can be one part of that plan—not a substitute for adequate staffing, and certainly not a way to treat learners as cheap labour.

Apprenticeships can build a staffing pipeline—if the plan is practical

An apprenticeship is a structured route to develop skills over time. For a pharmacy employer, the benefit is not an instant solution to an empty shift. It is the opportunity to support a learner to gain relevant knowledge and experience while working towards a recognised qualification, with training and workplace development built into the plan.

To make an apprenticeship useful to a pharmacy, work through the practical questions before recruiting:

Which role are you building? Be clear about the job, expected responsibilities and the skills the learner will need. Do not advertise a vague promise of “career progression” without explaining the next step.
Who will support the learner? Name the workplace supervisor or mentor and set aside time for check-ins. A learner needs guidance, feedback and opportunities to practise—not just a place on the rota.
How will training fit around service demand? Plan study and learning time alongside dispensing, consultations and shift cover. If every training hour disappears whenever the pharmacy gets busy, progress can stall.
What does success look like, and by when? Set milestones for onboarding, skills development and review. Check progress regularly rather than waiting for a problem to show up as a rota gap.
Can the pharmacy sustain the commitment? Consider staff cover, supervision capacity and the costs and funding rules that apply. Confirm current details with the training provider and relevant official guidance.

Training providers can help employers understand available programmes and what support they require. For example, Tend Training’s pharmacy apprenticeship training category page is a starting point for exploring pharmacy apprenticeship options. Employers should check the page and speak with the provider about current programmes, eligibility, delivery arrangements and employer responsibilities before making workforce plans.

Think in weeks, not just in headcount

A staffing pipeline only works when it translates into weekly actions. A pharmacy might schedule a protected learning session, hold a short supervisor check-in, review progress against agreed skills, and plan when the learner can take on defined tasks safely. Managers can then see whether the training plan is happening and whether the learner is building capability.

That level of planning also helps distinguish a genuine development role from a vacancy filled by someone who has not yet been given the support to succeed. Apprentices need supervision and a suitable learning environment. The pharmacy needs a realistic view of what the apprentice can contribute at each stage. Those two needs can coexist, but only with clear expectations.

Use funding figures to inform workforce decisions—not replace them

The £340 million increase is significant when comparing 2025/26 with 2024/25. But it is not an additional year-on-year CPCF uplift for 2026/27. The headline settlement stayed at approximately £3.073 billion, so pharmacies should avoid building plans on the assumption that a fresh £340 million has arrived in the current year.

Instead, owners can use a simple planning sequence:

Check the current official CPCF payment rules and confirm which services and payments apply to the pharmacy.
Compare income and costs over matching periods, and label the years clearly.
Map predictable workload, including Pharmacy First activity, against actual staffing hours.
Identify the roles that are difficult to recruit for and the skills the existing team needs.
Decide where recruitment, retention and apprenticeship training each fit—and assign someone to review progress.

This will not remove every workforce challenge. It does make the decisions more concrete: which service creates pressure, which shift needs cover, what skills the team lacks, and what support a learner would need to become a capable colleague.

The bottom line

The headline CPCF funding total for 2026/27 was approximately £3.073 billion, the same as in 2025/26. The frequently cited £340 million increase compares 2025/26 with 2024/25; it was not a new £340 million year-on-year funding increase for 2026/27.

With Pharmacy First adding clinical workload and workforce pressures affecting community pharmacies, a flat headline settlement makes careful planning more important—not less. Recruitment still matters, but it cannot carry the whole workforce strategy in a tight labour market. A realistic combination of hiring, retention and supported apprenticeship training can help pharmacies develop the skills they need over time, provided employers plan for supervision and protected learning as carefully as they plan the rota.